Accelerated, high spatial resolution cardiovascular magnetic resonance myocardial perfusion imaging

Journal of Nuclear Cardiology

Volumn 18, Issue 5, 2011, Pages 952-958

  Motwani, Manish ^a   Lockie, Timothy ^b   Greenwood, John P ^a   Plein, Sven ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELERATION; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING;

CORONARY ARTERY DISEASE; CORONARY CIRCULATION; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MYOCARDIAL PERFUSION IMAGING;

EID: 83255194117     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-011-9434-4     Document Type: Article

References (42)

1. Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: What is the warranty period of a normal scan? J Am Coll Cardiol 2003; 41:1329-40. (Pubitemid 36438995)
2. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003;42:1318-33. (Pubitemid 37188362)
3. Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993;22: 665-70. (Pubitemid 23256923)
4. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43. (Pubitemid 28090682)
5. Shaw LJ, Berman DS, Maron DJ, Mancini GBJ, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-91. (Pubitemid 351365675)
6. Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H, et al. MR-IMPACT: Comparison of perfusioncardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008;29: 480-9. (Pubitemid 351264187)
7. Wolff SD, Schwitter J, Coulden R, Friedrich MG, Bluemke DA, Biederman RW, et al. Myocardial first-pass perfusion magnetic resonance imaging: A multicenter dose-ranging study. Circulation 2004;110:732-7. (Pubitemid 39056274)
8. Keijer JT, van Rossum AC, Wilke N, van Eenige MJ, Jerosch- Herold M, Bronzwaer JG, et al. Magnetic resonance imaging of myocardial perfusion in single-vessel coronary artery disease: Implications for transmural assessment of myocardial perfusion. J Cardiovasc Magn Reson 2000;2:189-200.
9. Keijer JT, van Rossum AC, van Eenige MJ, Bax JJ, Visser FC, Teule JJ, et al. Magnetic resonance imaging of regional myocardial perfusion in patients with single-vessel coronary artery disease: Quantitative comparison with (201)Thallium-SPECT and coronary angiography. J Magn Reson Imaging 2000;11:607-15. (Pubitemid 30350303)
10. Sakuma H, Suzawa N, Ichikawa Y, Makino K, Hirano T, Kitagawa K, et al. Diagnostic accuracy of stress first-pass contrastenhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy. AJR Am J Roentgenol 2005;185: 95-102.
11. Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, et al. Clinical evaluation of magnetic resonance imaging in coronary heart disease (The CE-MARC Study): A prospective evaluation of 750 patients (Abstract). Circulation 2010;122:A21797.
12. Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R, et al. Prognostic value of cardiac magnetic resonance stress tests: Adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 2007;115:1769-76. (Pubitemid 46648614)
13. Atkinson DJ, Burstein D, Edelman RR. First-pass cardiac perfusion: Evaluation with ultrafast MR imaging. Radiology 1990;174: 757-62. (Pubitemid 20089667)
14. Kellman P, Arai AE. Imaging sequences for first pass perfusion- A review. J Cardiovasc Magn Reson 2007;9:525-37. (Pubitemid 46399023)
15. Gebker R, Schwitter J, Fleck E, Nagel E. How we perform myocardial perfusion with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2007;9:539-47. (Pubitemid 46399022)
16. Gerber BL. MR perfusion imaging. What will be its impact for detection of coronary disease in the future? Eur Heart J 2008; 29:434-5. (Pubitemid 351264196)
17. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343:1445-53.
18. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-53. (Pubitemid 34651354)
19. Plein S, Greenwood JP, Ridgway JP, Cranny G, Ball SG, Sivananthan MU. Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol 2004;44:2173-81. (Pubitemid 39576037)
20. Bodi V, Sanchis J, Lopez-Lereu MP, Losada A, Nunez J, Pellicer M, et al. Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. J Am Coll Cardiol 2005;46:1747-52. (Pubitemid 41531634)
21. Kozerke S, Plein S. Accelerated CMR using zonal, parallel and prior knowledge driven imaging methods. J Cardiovasc Magn Reson 2008;10:29.
22. Tsao J, Boesiger P, Pruessmann KP. k-t BLAST and k-t SENSE: Dynamic MRI with high frame rate exploiting spatiotemporal correlations. Magn Reson Med 2003;50:1031-42. (Pubitemid 37356583)
23. Ge L, Kino A, Griswold M, Mistretta C, Carr JC, Li D. Myocardial perfusion MRI with sliding-window conjugate-gradient HYPR. Magn Reson Med 2009;62:835-9.
24. Plein S, Ryf S, Schwitter J, Radjenovic A, Boesiger P, Kozerke S. Dynamic contrast-enhanced myocardial perfusion MRI accelerated with k-t sense. Magn Reson Med 2007;58:777-85. (Pubitemid 47556883)
25. Maredia N, Radjenovic A, Kozerke S, Larghat A, Greenwood JP, Plein S. Effect of improving spatial or temporal resolution on image quality and quantitative perfusion assessment with k-t SENSE acceleration in first-pass CMR myocardial perfusion imaging. Magn Reson Med 2010;64:1616-24.
26. Di Bella EVR, Parker DL, Sinusas AJ. On the dark rim artifact in dynamic contrast-enhanced MRI myocardial perfusion studies. Magn Reson Med 2005;54:1295-9. (Pubitemid 41567212)
27. Plein S, Kozerke S, Suerder D, Luescher TF, Greenwood JP, Boesiger P, et al. High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease. Eur Heart J 2008;29:2148-55.
28. Plein S, Schwitter J, Suerder D, Greenwood JP, Boesiger P, Kozerke S. k-Space and time sensitivity encoding-Accelerated myocardial perfusion MR imaging at 3.0 T: Comparison with 1.5 T1. Radiology 2008;249:493-500.
29. Manka R, Vitanis V, Boesiger P, Flammer AJ, Plein S, Kozerke S. Clinical feasibility of accelerated, high spatial resolution myocardial perfusion imaging. JACC Cardiovasc Imaging 2010;3:710-7.
30. Cheng ASH, Pegg TJ, Karamitsos TD, Searle N, Jerosch-Herold M, Choudhury RP, et al. Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: A comparison with 1.5-tesla. J Am Coll Cardiol 2007; 49:2440-9. (Pubitemid 46962268)
31. Bartunek J, Sys SU, Heyndrickx GR, Pijls NHJ, De Bruyne B. Quantitative coronary angiography in predicting functional significance of stenoses in an unselected patient cohort. J Am Coll Cardiol 1995;26:328-34.
32. Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010;56:177-84.
33. Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van't Veer M, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER study. J Am Coll Cardiol 2007;49:2105-11. (Pubitemid 46771047)
34. Pijls NH, de Bruyne B, Peels K, van der Voort PH, Bonnier HJ, Bartunek J, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703-9.
35. Lockie T, Ishida M, Perera D, Chiribiri A, De Silva K, Kozerke S, et al. High-resolution magnetic resonance myocardial perfusion imaging at 3.0-Tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve. J Am Coll Cardiol 2010;57:70-5.
36. Tonino PA, Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study: Fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 2010;55:2816-21.
37. King's College London. MR INFORM-MR perfusion imaging to guide management of patients with stable coronary artery disease. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US); 2000. Available from: http://clinicaltrials.gov/ct2/show/NCT01236807.
38. Bache RJ, Schwartz JS. Effect of perfusion pressure distal to a coronary stenosis on transmural myocardial blood flow. Circulation 1982;65:928-35. (Pubitemid 12150522)
39. Stanton T, Marwick TH. Assessment of subendocardial structure and function. JACC Cardiovasc Imaging 2010;3:867-75.
40. Brown KA, Boucher CA, Okada RD, Guiney TE, Newell JB, Strauss HW, et al. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol 1983;1:994-1001. (Pubitemid 13107519)
41. Manka R, Jahnke C, Kozerke S, Vitanis V, Crelier G, Gebker R, et al. Dynamic 3-dimensional stress cardiac magnetic resonance perfusion imaging: Detection of coronary artery disease and volumetry of myocardial hypoenhancement before and after coronary stenting. J Am Coll Cardiol 2011;57:437-44.
42. Shin T, Hu HH, Pohost GM, Nayak KS. Three dimensional firstpass myocardial perfusion imaging at 3T: Feasibility study. J Cardiovasc Magn Reson 2008;10:57.